Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area

G

Ghent University Hospital (UZ)

Status and phase

Terminated
Phase 1

Conditions

Head and Neck Tumors

Treatments

Radiation: GRID radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT00528294
2007/010

Details and patient eligibility

About

This trials examines the feasibility of GRID-therapy combined with biologically imaging based IMRT (BG-IMRT). Within this trial, the strict toxicity parameters of primary treatment of head and neck tumors are used. The GRID and BG-IMRT technique might be possible to reduce the total radiation dose 2 to 3 times.

Enrollment

12 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Recurrent or new head or neck tumor
  • 18 years or older

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

1
Experimental group
Description:
GRID-radiotherapy followed by biological imaging guided IMRT
Treatment:
Radiation: GRID radiotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems